series-a
Stage
2
Investors
About
Alixia develops therapeutics that disrupt the metabolic and inflammatory interactions within the tumor microenvironment to overcome cancer drug resistance and improve treatment efficacy.
Explore Alixia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.